55513-481 : Amjevita 80 mg/.8ml Subcutaneous Injection


NDC: 55513-481
Labeler: Amgen Inc
Product Type: Human Prescription Drug
Drug Name:  Amjevita
Dosage Form: Subcutaneous Injection
Application #: BLA761024
Rev. Date: 


NDC Package Codes:

  • 55513-481-01: 1 SYRINGE IN 1 CARTON (55513‑481‑01) / .8 ML IN 1 SYRINGE
  • 55513-481-02: 2 SYRINGE IN 1 CARTON (55513‑481‑02) / .8 ML IN 1 SYRINGE

Active Ingredients:

  • Adalimumab

Dosage Strength:

  • 80 mg/.8mL

Pharmaceutical Classes:

  • Antibodies
  • Monoclonal [CS]
  • Tumor Necrosis Factor Blocker [EPC]
  • Tumor Necrosis Factor Receptor Blocking Activity [MoA]

Related Products:

Based on records with the same trade name.
  • 55513-399 Amjevita 20 mg/.2ml Subcutaneous Injection by Amgen Inc
  • 55513-400 Amjevita 40 mg/.8ml Subcutaneous Injection by Amgen Inc
  • 55513-410 Amjevita 40 mg/.8ml Subcutaneous Injection by Amgen Inc
  • 55513-411 Amjevita 20 mg/.4ml Subcutaneous Injection by Amgen Inc
  • 55513-413 Amjevita 10 mg/.2ml Subcutaneous Injection by Amgen Inc
  • 55513-479 Amjevita 40 mg/.4ml Subcutaneous Injection by Amgen Inc
  • 55513-480 Amjevita 80 mg/.8ml Subcutaneous Injection by Amgen Inc
  • 55513-482 Amjevita 40 mg/.4ml Subcutaneous Injection by Amgen Inc
  • 50090-6411 Amjevita 40 mg/.8ml Subcutaneous Injection by A-s Medication Solutions
  • 50090-6428 Amjevita 40 mg/.8ml Subcutaneous Injection by A-s Medication Solutions
  • 72511-400 Amjevita 40 mg/.8ml Subcutaneous Injection by Amgen USA Inc.
  • 72511-482 Amjevita 40 mg/.4ml Subcutaneous Injection by Amgen USA Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 55513-481 QR Code

< Prev: 55513-480Next: 55513-482 >

Related Discussions:

Humira (adalimumab) for pain
I’m on Humira (adalimumab) for RA joint pain and would like to know how other people are doing on it? I’m do... 2 replies




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.